This invention relates to novel compounds that can complex with lanthanide cations processes for their preparation and the use of the resulting lanthanide chelates as biomolecular probes.

The present invention is directed to methods for the control of strains of bio-hazardous bacterial agents. These agents include: Bacillus anthracis Yersinia Pestis Francisella tularensis Clostridium botulinin Clostridium Perfringens Brucella abortis B milletensis B suis and Burkholderia mallei. These methods employ treating an infected warm-blooded animal with an antibiotics selected from: Cephalothin Cefazolin Cephalexin monohydrate Cephalexin HCl Cefaclor Loracarbef Erythromycin estolate Dirit...

This invention relates to novel compounds that can complex with lanthanide cations, processes for their preparation and the use of the resulting lanthanide chelates as biomolecular probes.

This invention relates to novel compounds that can complex with lanthanide cations processes for their preparation and the use of the resulting lanthanide chelates as biomolecular probes.

This invention relates to novel compounds that can complex with lanthanide cations, processes for their preparation and the use of the resulting lanthanide chelates as biomolecular probes.

PURPOSE: To obtain a liquid pharmaceutical composition containing 4-quilone derivative forming a complex with a specific divalent metal ion capable of preserving the composition for a long period free from crystalline growth.CONSTITUTION: This liquid pharmaceutical composition includes 4-quinolone derivative e.g. nalidixic acid oxolinic acid pipemidic acid cinoxacin and flumequin especially norfloxacin complexed with a divalent metal ion selected from Cu(sup ++) Zn(sup ++) and Mg(sup ++) suspend...

PURPOSE: To obtain a liquid pharmaceutical composition containing 4-quilone derivative forming a complex with a specific divalent metal ion capable of preserving the composition for a long period free from crystalline growth. CONSTITUTION: This liquid pharmaceutical composition includes 4-quinolone derivative e.g. nalidixic acid oxolinic acid pipemidic acid cinoxacin and flumequin especially norfloxacin complexed with a divalent metal ion selected from Cu Zn and Mg suspended in a particle form...